| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |